These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma. El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221 [TBL] [Abstract][Full Text] [Related]
4. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations. Raptis I; Koskinas J; Emmanouil T; Hadziyannis S J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179 [TBL] [Abstract][Full Text] [Related]
5. Natural history of chronic hepatitis B REVEALed. Chen CJ; Yang HI J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729 [TBL] [Abstract][Full Text] [Related]
6. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration. Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644 [TBL] [Abstract][Full Text] [Related]
9. Perspectives and control of hepatitis B virus infection in Taiwan. Lin CL; Kao JH J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565 [TBL] [Abstract][Full Text] [Related]
10. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort. Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689 [TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection. Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431 [TBL] [Abstract][Full Text] [Related]
12. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ; Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622 [TBL] [Abstract][Full Text] [Related]
13. [HBV and HCV coinfections in children--own investigations]. Pawłowska M; Halota W Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164 [TBL] [Abstract][Full Text] [Related]
14. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099 [TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662 [TBL] [Abstract][Full Text] [Related]
16. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418 [TBL] [Abstract][Full Text] [Related]
17. Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients. Darwish MA; Amer AF; El-Moeity AA; Darwish NM J Egypt Public Health Assoc; 1997; 72(5-6):569-89. PubMed ID: 17214153 [TBL] [Abstract][Full Text] [Related]
18. Risk stratification for hepatitis B virus related hepatocellular carcinoma. Lin CL; Kao JH J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699 [TBL] [Abstract][Full Text] [Related]
19. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
20. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Iloeje UH; Yang HI; Chen CJ Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]